世界の肝線維症治療薬市場レポート2020年

【英語タイトル】Global Liver Fibrosis Drug Sales Market Report 2020

QYResearchが出版した調査資料(QYR20JN01954)・商品コード:QYR20JN01954
・発行会社(調査会社):QYResearch
・発行日:2020年6月
・ページ数:139
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥684,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥912,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
QYリサーチ社の本調査レポートでは、世界の肝線維症治療薬市場について種類別(ヌクレオシド、インターフェロン、その他)、用途別(肝炎、肝線維症、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・肝線維症治療薬市場の概要
・世界の主要地域別肝線維症治療薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の肝線維症治療薬市場規模2015-2026:種類別(ヌクレオシド、インターフェロン、その他)
・世界の肝線維症治療薬市場規模2015-2026:用途別(肝炎、肝線維症、その他)
・肝線維症治療薬の北米市場規模2015-2020
・肝線維症治療薬のヨーロッパ市場規模2015-2020
・肝線維症治療薬の中国市場規模2015-2020
・肝線維症治療薬の日本市場規模2015-2020
・肝線維症治療薬の東南アジア市場規模2015-2020
・肝線維症治療薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Gilead、Biogen Idec、Merck KGaA、Bristol-Myers Squibb Company、Roche、Merck & Co.、Tri-Prime)
・肝線維症治療薬の製造コスト分析
・販売チャネル、流通業者、顧客
・肝線維症治療薬の市場動向・機会・課題
・調査の結論
【レポートの概要】

Liver fibrosis is the scarring process that represents the liver’s response to injury. In the same way as skin and other organs heal wounds through deposition of collagen and other matrix constituents so the liver repairs injury through the deposition of new collagen.
The classification of Liver Fibrosis Drug includes nucleoside, interferon and others, and the proportion of nucleoside type in 2018 is about 45.37%, and the proportion keeps stable trend from 2014 to 2025.Liver fibrosis drug is widely used for Hepatitis, Liver Fibrosis and Other. The most proportion of Interferon is used for hepatitis, and the proportion in 2018 is 68.37%.

Market Analysis and Insights: Global Liver Fibrosis Drug Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Liver Fibrosis Drug market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Liver Fibrosis Drug industry.
Based on our recent survey, we have several different scenarios about the Liver Fibrosis Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 13790 million in 2019. The market size of Liver Fibrosis Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global Liver Fibrosis Drug Scope and Market Size
The global Liver Fibrosis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Liver Fibrosis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Liver Fibrosis Drug market is segmented into
Nucleoside
Interferon
Other

Segment by Application, the Liver Fibrosis Drug market is segmented into
Hepatitis
Liver Fibrosis
Other

The Liver Fibrosis Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Liver Fibrosis Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Liver Fibrosis Drug Market Share Analysis
Liver Fibrosis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Liver Fibrosis Drug business, the date to enter into the Liver Fibrosis Drug market, Liver Fibrosis Drug product introduction, recent developments, etc.

The major vendors covered:
Gilead
Biogen Idec
Merck KGaA
Bristol-Myers Squibb Company
Roche
Merck & Co.
Tri-Prime

【レポートの目次】

1 Liver Fibrosis Drug Market Overview
1.1 Liver Fibrosis Drug Product Scope
1.2 Liver Fibrosis Drug Segment by Type
1.2.1 Global Liver Fibrosis Drug Sales by Type (2020-2026)
1.2.2 Nucleoside
1.2.3 Interferon
1.2.4 Other
1.3 Liver Fibrosis Drug Segment by Application
1.3.1 Global Liver Fibrosis Drug Sales Comparison by Application (2020-2026)
1.3.2 Hepatitis
1.3.3 Liver Fibrosis
1.3.4 Other
1.4 Liver Fibrosis Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Liver Fibrosis Drug Sales Growth Rate (2015-2026)
1.4.2 Global Liver Fibrosis Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Liver Fibrosis Drug Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Liver Fibrosis Drug Industry Impact
1.5.1 How the Covid-19 is Affecting the Liver Fibrosis Drug Industry
1.5.1.1 Liver Fibrosis Drug Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Liver Fibrosis Drug Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Liver Fibrosis Drug Players to Combat Covid-19 Impact

2 Liver Fibrosis Drug Estimate and Forecast by Region
2.1 Global Liver Fibrosis Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Liver Fibrosis Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Liver Fibrosis Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Liver Fibrosis Drug Revenue Market Share by Region (2015-2020)
2.3 Global Liver Fibrosis Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Liver Fibrosis Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Liver Fibrosis Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Liver Fibrosis Drug Estimates and Projections (2015-2026)
2.4.2 Europe Liver Fibrosis Drug Estimates and Projections (2015-2026)
2.4.3 China Liver Fibrosis Drug Estimates and Projections (2015-2026)
2.4.4 Japan Liver Fibrosis Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Liver Fibrosis Drug Estimates and Projections (2015-2026)
2.4.6 India Liver Fibrosis Drug Estimates and Projections (2015-2026)
3 Global Liver Fibrosis Drug Competition Landscape by Players
3.1 Global Top Liver Fibrosis Drug Players by Sales (2015-2020)
3.2 Global Top Liver Fibrosis Drug Players by Revenue (2015-2020)
3.3 Global Liver Fibrosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Fibrosis Drug as of 2019)
3.4 Global Liver Fibrosis Drug Average Price by Company (2015-2020)
3.5 Manufacturers Liver Fibrosis Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Liver Fibrosis Drug Players (Opinion Leaders)
4 Global Liver Fibrosis Drug Market Size by Type
4.1 Global Liver Fibrosis Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Liver Fibrosis Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Liver Fibrosis Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Liver Fibrosis Drug Price by Type (2014-2020)
4.2 Global Liver Fibrosis Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Liver Fibrosis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Liver Fibrosis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Liver Fibrosis Drug Price Forecast by Type (2021-2026)
5 Global Liver Fibrosis Drug Market Size by Application
5.1 Global Liver Fibrosis Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Liver Fibrosis Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Liver Fibrosis Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Liver Fibrosis Drug Price by Application (2015-2020)
5.2 Global Liver Fibrosis Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Liver Fibrosis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Liver Fibrosis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Liver Fibrosis Drug Price Forecast by Application (2021-2026)

3 North America Liver Fibrosis Drug Market Facts & Figures
3.2 North America Liver Fibrosis Drug Sales Market Share by Company (2015-2020)
3.3 North America Liver Fibrosis Drug Sales Market Share by Type (2015-2020)
3.4 North America Liver Fibrosis Drug Sales Market Share by Application (2015-2020)

4 Europe Liver Fibrosis Drug Market Facts & Figures
4.2 Europe Liver Fibrosis Drug Sales Market Share by Company (2015-2020)
4.3 Europe Liver Fibrosis Drug Sales Market Share by Type (2015-2020)
4.4 Europe Liver Fibrosis Drug Sales Market Share by Application (2015-2020)

5 China Liver Fibrosis Drug Market Facts & Figures
5.2 China Liver Fibrosis Drug Sales Market Share by Company (2015-2020)
5.3 China Liver Fibrosis Drug Sales Market Share by Type (2015-2020)
5.4 China Liver Fibrosis Drug Sales Market Share by Application (2015-2020)

6 Japan Liver Fibrosis Drug Market Facts & Figures
6.2 Japan Liver Fibrosis Drug Sales Market Share by Company (2015-2020)
6.3 Japan Liver Fibrosis Drug Sales Market Share by Type (2015-2020)
6.4 Japan Liver Fibrosis Drug Sales Market Share by Application (2015-2020)

7 Southeast Asia Liver Fibrosis Drug Market Facts & Figures
7.2 Southeast Asia Liver Fibrosis Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Liver Fibrosis Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Liver Fibrosis Drug Sales Market Share by Application (2015-2020)

8 India Liver Fibrosis Drug Market Facts & Figures
8.2 India Liver Fibrosis Drug Sales Market Share by Company (2015-2020)
8.3 India Liver Fibrosis Drug Sales Market Share by Type (2015-2020)
8.4 India Liver Fibrosis Drug Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Liver Fibrosis Drug Business
12.1 Gilead
12.1.1 Gilead Liver Fibrosis Drug Corporation Information
12.1.2 Gilead Liver Fibrosis Drug Business Overview and Total Revenue
12.1.3 Gilead Liver Fibrosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Gilead Liver Fibrosis Drug Products Offered
12.1.5 Gilead Recent Development
12.2 Biogen Idec
12.2.1 Biogen Idec Liver Fibrosis Drug Corporation Information
12.2.2 Biogen Idec Liver Fibrosis Drug Business Overview and Total Revenue
12.2.3 Biogen Idec Liver Fibrosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Biogen Idec Liver Fibrosis Drug Products Offered
12.2.5 Biogen Idec Recent Development
12.3 Merck KGaA
12.3.1 Merck KGaA Liver Fibrosis Drug Corporation Information
12.3.2 Merck KGaA Liver Fibrosis Drug Business Overview and Total Revenue
12.3.3 Merck KGaA Liver Fibrosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck KGaA Liver Fibrosis Drug Products Offered
12.3.5 Merck KGaA Recent Development
12.4 Bristol-Myers Squibb Company
12.4.1 Bristol-Myers Squibb Company Liver Fibrosis Drug Corporation Information
12.4.2 Bristol-Myers Squibb Company Liver Fibrosis Drug Business Overview and Total Revenue
12.4.3 Bristol-Myers Squibb Company Liver Fibrosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bristol-Myers Squibb Company Liver Fibrosis Drug Products Offered
12.4.5 Bristol-Myers Squibb Company Recent Development
12.5 Roche
12.5.1 Roche Liver Fibrosis Drug Corporation Information
12.5.2 Roche Liver Fibrosis Drug Business Overview and Total Revenue
12.5.3 Roche Liver Fibrosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Roche Liver Fibrosis Drug Products Offered
12.5.5 Roche Recent Development
12.6 Merck & Co.
12.6.1 Merck & Co. Liver Fibrosis Drug Corporation Information
12.6.2 Merck & Co. Liver Fibrosis Drug Business Overview and Total Revenue
12.6.3 Merck & Co. Liver Fibrosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Merck & Co. Liver Fibrosis Drug Products Offered
12.6.5 Merck & Co. Recent Development
12.7 Tri-Prime
12.7.1 Tri-Prime Liver Fibrosis Drug Corporation Information
12.7.2 Tri-Prime Liver Fibrosis Drug Business Overview and Total Revenue
12.7.3 Tri-Prime Liver Fibrosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Tri-Prime Liver Fibrosis Drug Products Offered
12.7.5 Tri-Prime Recent Development

13 Liver Fibrosis Drug Manufacturing Cost Analysis
13.1 Liver Fibrosis Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Liver Fibrosis Drug
13.4 Liver Fibrosis Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Liver Fibrosis Drug Distributors List
14.3 Liver Fibrosis Drug Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Liver Fibrosis Drug Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Liver Fibrosis Drug Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Liver Fibrosis Drug Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Liver Fibrosis Drug Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Liver Fibrosis Drug Players to Combat Covid-19 Impact
Table 8. Global Market Liver Fibrosis Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Liver Fibrosis Drug Sales (K Units) by Region (2015-2020)
Table 10. Global Liver Fibrosis Drug Sales Market Share by Region (2015-2020)
Table 11. Global Liver Fibrosis Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Liver Fibrosis Drug Revenue Share by Region (2015-2020)
Table 13. Global Liver Fibrosis Drug Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Liver Fibrosis Drug Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Liver Fibrosis Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Liver Fibrosis Drug Revenue Share Forecast by Region (2021-2026)
Table 17. Global Liver Fibrosis Drug (K Units) of Key Companies (2015-2020)
Table 18. Global Liver Fibrosis Drug Sales Share by Company (2015-2020)
Table 19. Global Liver Fibrosis Drug Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Liver Fibrosis Drug Revenue Share by Company (2015-2020)
Table 21. Global Liver Fibrosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Fibrosis Drug as of 2019)
Table 22. Global Liver Fibrosis Drug Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Liver Fibrosis Drug Manufacturing Sites and Area Served
Table 24. Manufacturers Liver Fibrosis Drug Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Liver Fibrosis Drug Players
Table 27. Global Liver Fibrosis Drug Sales (K Units) by Type (2015-2020)
Table 28. Global Liver Fibrosis Drug Sales Share by Type (2015-2020)
Table 29. Global Liver Fibrosis Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Liver Fibrosis Drug Price (K Units) by Type (2015-2020)
Table 31. Global Liver Fibrosis Drug Sales Share by Type (2021-2026)
Table 32. Global Liver Fibrosis Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Liver Fibrosis Drug Revenue Share by Type (2021-2026)
Table 34. Global Liver Fibrosis Drug Price (K Units) by Type (2021-2026)
Table 35. Global Liver Fibrosis Drug Sales (K Units) by Application (2015-2020)
Table 36. Global Liver Fibrosis Drug Sales Share by Application (2015-2020)
Table 37. Global Liver Fibrosis Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Liver Fibrosis Drug Price (K Units) by Application (2015-2020)
Table 39. Global Liver Fibrosis Drug Sales (K Units) by Application (2021-2026)
Table 40. Global Liver Fibrosis Drug Sales Share by Application (2021-2026)
Table 41. Global Liver Fibrosis Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Liver Fibrosis Drug Revenue Share by Application (2021-2026)
Table 43. Global Liver Fibrosis Drug Price (K Units) by Application (2021-2026)
Table 44. United States Liver Fibrosis Drug Sales (K Units) by Company (2015-2020)
Table 45. United States Liver Fibrosis Drug Sales Market Share by Company (2015-2020)
Table 46. United States Liver Fibrosis Drug Sales (K Units) by Type (2015-2020)
Table 47. United States Liver Fibrosis Drug Sales Market Share by Type (2015-2020)
Table 48. United States Liver Fibrosis Drug Sales (K Units) by Application (2015-2020)
Table 49. United States Liver Fibrosis Drug Sales Market Share by Application (2015-2020)
Table 50. Europe Liver Fibrosis Drug Sales (K Units) by Company (2015-2020)
Table 51. Europe Liver Fibrosis Drug Sales Market Share by Company (2015-2020)
Table 52. Europe Liver Fibrosis Drug Sales (K Units) by Type (2015-2020)
Table 53. Europe Liver Fibrosis Drug Sales Market Share by Type (2015-2020)
Table 54. Europe Liver Fibrosis Drug Sales (K Units) by Application (2015-2020)
Table 55. Europe Liver Fibrosis Drug Sales Market Share by Type (2015-2020)
Table 56. China Liver Fibrosis Drug Sales (K Units) by Company (2015-2020)
Table 57. China Liver Fibrosis Drug Sales Market Share by Company (2015-2020)
Table 58. China Liver Fibrosis Drug Sales (K Units) by Type (2015-2020)
Table 59. China Liver Fibrosis Drug Sales Market Share by Type (2015-2020)
Table 60. China Liver Fibrosis Drug Sales (K Units) by Application (2015-2020)
Table 61. China Liver Fibrosis Drug Sales Market Share by Application (2015-2020)
Table 62. Japan Liver Fibrosis Drug Sales (K Units) by Company (2015-2020)
Table 63. Japan Liver Fibrosis Drug Sales Market Share by Company (2015-2020)
Table 64. Japan Liver Fibrosis Drug Sales (K Units) by Type (2015-2020)
Table 65. Japan Liver Fibrosis Drug Sales Market Share by Type (2015-2020)
Table 66. Japan Liver Fibrosis Drug Sales (K Units) by Application (2015-2020)
Table 67. Japan Liver Fibrosis Drug Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Liver Fibrosis Drug Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Liver Fibrosis Drug Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Liver Fibrosis Drug Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Liver Fibrosis Drug Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Liver Fibrosis Drug Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Liver Fibrosis Drug Sales Market Share by Application (2015-2020)
Table 74. India Liver Fibrosis Drug Sales (K Units) by Company (2015-2020)
Table 75. India Liver Fibrosis Drug Sales Market Share by Company (2015-2020)
Table 76. India Liver Fibrosis Drug Sales (K Units) by Type (2015-2020)
Table 77. India Liver Fibrosis Drug Sales Market Share by Type (2015-2020)
Table 78. India Liver Fibrosis Drug Sales (K Units) by Application (2015-2020)
Table 79. India Liver Fibrosis Drug Sales Market Share by Application (2015-2020)
Table 80. Gilead Corporation Information
Table 81. Gilead Description and Business Overview
Table 82. Gilead Liver Fibrosis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Gilead Liver Fibrosis Drug Product
Table 84. Gilead Recent Development
Table 85. Biogen Idec Corporation Information
Table 86. Biogen Idec Description and Business Overview
Table 87. Biogen Idec Liver Fibrosis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Biogen Idec Liver Fibrosis Drug Product
Table 89. Biogen Idec Recent Development
Table 90. Merck KGaA Corporation Information
Table 91. Merck KGaA Description and Business Overview
Table 92. Merck KGaA Liver Fibrosis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Merck KGaA Liver Fibrosis Drug Product
Table 94. Merck KGaA Recent Development
Table 95. Bristol-Myers Squibb Company Corporation Information
Table 96. Bristol-Myers Squibb Company Description and Business Overview
Table 97. Bristol-Myers Squibb Company Liver Fibrosis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Bristol-Myers Squibb Company Liver Fibrosis Drug Product
Table 99. Bristol-Myers Squibb Company Recent Development
Table 100. Roche Corporation Information
Table 101. Roche Description and Business Overview
Table 102. Roche Liver Fibrosis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Roche Liver Fibrosis Drug Product
Table 104. Roche Recent Development
Table 105. Merck & Co. Corporation Information
Table 106. Merck & Co. Description and Business Overview
Table 107. Merck & Co. Liver Fibrosis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Merck & Co. Liver Fibrosis Drug Product
Table 109. Merck & Co. Recent Development
Table . Tri-Prime Corporation Information
Table . Tri-Prime Description and Business Overview
Table . Tri-Prime Liver Fibrosis Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Tri-Prime Liver Fibrosis Drug Product
Table . Tri-Prime Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Liver Fibrosis Drug Distributors List
Table 118. Liver Fibrosis Drug Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Liver Fibrosis Drug Product Picture
Figure 2. Global Liver Fibrosis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Liver Fibrosis Drug Market Share by Application in 2020 & 2026
Figure 6. Hepatitis Examples
Figure 7. Liver Fibrosis Examples
Figure 8. Other Examples
Figure 9. Global Liver Fibrosis Drug Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Liver Fibrosis Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Liver Fibrosis Drug Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Liver Fibrosis Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Liver Fibrosis Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Liver Fibrosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Liver Fibrosis Drug Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Liver Fibrosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Liver Fibrosis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Liver Fibrosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Liver Fibrosis Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Liver Fibrosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Liver Fibrosis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Liver Fibrosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Liver Fibrosis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Liver Fibrosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Liver Fibrosis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Liver Fibrosis Drug Players Market Share by Revenue in Liver Fibrosis Drug 2015 & 2019
Figure 27. Liver Fibrosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Liver Fibrosis Drug Revenue Share by Type (2015-2020)
Figure 29. Global Liver Fibrosis Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Liver Fibrosis Drug Revenue Share by Application (2015-2020)
Figure 31. Global Liver Fibrosis Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Liver Fibrosis Drug Sales Market Share by Type in 2019
Figure 33. United States Liver Fibrosis Drug Sales Market Share by Type in 2019
Figure 34. Europe Liver Fibrosis Drug Sales Market Share by Company in 2019
Figure 35. Europe Liver Fibrosis Drug Sales Market Share by Type in 2019
Figure 36. Europe Liver Fibrosis Drug Sales Market Share by Application in 2019
Figure 37. China Liver Fibrosis Drug Sales Market Share by Company in 2019
Figure 38. China Liver Fibrosis Drug Sales Market Share by Type in 2019
Figure 39. China Liver Fibrosis Drug Sales Market Share by Application in 2019
Figure 40. Japan Liver Fibrosis Drug Sales Market Share by Company in 2019
Figure 41. Japan Liver Fibrosis Drug Sales Market Share by Type in 2019
Figure 42. Japan Liver Fibrosis Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Liver Fibrosis Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Liver Fibrosis Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Liver Fibrosis Drug Sales Market Share by Application in 2019
Figure 46. India Liver Fibrosis Drug Sales Market Share by Company in 2019
Figure 47. India Liver Fibrosis Drug Sales Market Share by Type in 2019
Figure 48. India Liver Fibrosis Drug Sales Market Share by Application in 2019
Figure 49. Gilead Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Biogen Idec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Tri-Prime Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Liver Fibrosis Drug
Figure 58. Manufacturing Process Analysis of Liver Fibrosis Drug
Figure 59. Liver Fibrosis Drug Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


【掲載企業】

Gilead、Biogen Idec、Merck KGaA、Bristol-Myers Squibb Company、Roche、Merck & Co.、Tri-Prime

【レポートのキーワード】

肝線維症治療薬、ヌクレオシド、インターフェロン、肝炎、肝線維症

★調査レポート[世界の肝線維症治療薬市場レポート2020年] (コード:QYR20JN01954)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の肝線維症治療薬市場レポート2020年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆